Careers  |  Sign In  |  Register

Latest in Arthritis

Reuters Health • The Doctor's Channel Daily Newscast

Hydroxychloroquine improves lipid profiles in rheumatoid arthritis patients

NEW YORK (Reuters Health) – Hydroxychloroquine may reduce the heightened risk of cardiovascular disease in patients with rheumatoid arthritis. Use of hydroxychloroquine to treat rheumatoid arthritis is associated with reductions in cholesterol and triglycerides, a team with the Geisinger Health System in...

Reuters Health • The Doctor's Channel Daily Newscast

Tocilizumab effective for rheumatoid arthritis when methotrexate insufficient

NEW YORK (Reuters Health) - The IL-6 receptor-blocking monoclonal antibody tocilizumab inhibits joint damage in patients with rheumatoid arthritis that is not adequately controlled with methotrexate, according to study results reported in the November 19th online issue of Arthritis & Rheumatism. In...

Reuters Health • The Doctor's Channel Daily Newscast

Doxycycline’s anti-osteoarthritis effect reduced in bowlegged women

NEW YORK (Reuters Health) - The extent to which doxycycline slows the progression of knee osteoarthritis (OA) is not the same in neutrally aligned (non-varus) and malaligned (varus, or "bowlegged") knees, according to a post hoc analysis of a randomized controlled trial. "Varus malalignment negated the...